Details

Autor(en) / Beteiligte

• Kumar, Putha Suman
• Srinivas, Challapalli
• Vadhiraja, B M
• Banerjee, Sourjya
• Shreyas, R
• Prakash Saxena, P U
• Ravichandran, Ramamoorthy
• Lobo, Dilson

Titel

Simultaneous Measurement of In vivo and Transit Mid-Plane Doses with Ionization Chambers in Gynecological Malignancy Patients Undergoing Three-Dimensional Conformal Radiotherapy

Ist Teil von

• Journal of medical physics, 2020-04, Vol.45 (2), p.123-129

Ort / Verlag

India: Medknow Publications and Media Pvt. Ltd

Erscheinungsjahr

2020

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• The aim of this study is to estimate delivered radiation doses inside planning tumor volume (PTV) using the (mid-plane dose) measurement and transit measurement methods in gynecological malignancy patients undergoing three-dimensional conformal radiotherapy (3DCRT) using calibrated ionization chambers. Six patients with histopathologically proven carcinoma of the cervix or endometrium were planned with four-field 3DCRT to the pelvic site. Isocenter was at the geometric mid-plane of PTV with a dose prescription of 50 Gy in 25 fractions. Clinical mid-plane dose (D estimates were done in one method (transit) using the FC-65 positioned at electronic portal imaging device level. In another method, a repeat computerized tomography scan was performed (at the 11 fraction) using CC-13 having a protective cap in the vaginal cavity for measurements (D ). Simultaneous measurements were performed with the two chambers from the 11 fraction onward at least 3-4 times during the remaining course of treatment. The agreement of mean doses from these two described methods and treatment planning system reference doses was in the range of -4.4 ± 1.1% (minimum) to -0.3 ± 2.0% (maximum) and -4.0 ± 1.7% (minimum) to 1.9 ± 2.4% for D D , respectively, which are an acceptable range of daily radiation dose delivery. The fundamental importance of this study lies in simultaneous validation of delivered dose in real time with two methods. A study in this small number of patients has given the confidence to apply transit measurements for quality assurance on a routine basis as an accepted clinical dosimetry for the selected patients.